Role of the hemodialysis vascular access type in inflammation status and monocyte activation

Luigi Colì1, Gabriele Donati, Maria L Cappuccilli

  • 1Nephrology, Dialysis and Renal Transplant Unit, S Orsola University Hospital, Bologna, Italy.

Insights

Arterovenous grafts (AVG) and tunneled cuffed catheters (TCC) used for hemodialysis are linked to increased inflammation and monocyte activation compared to arterovenous fistulas (AVF). These access types promote monocyte senescence, impacting patient inflammatory status.

Area of Science:

  • Nephrology
  • Immunology
  • Vascular Surgery

Background:

  • Hemodialysis requires reliable vascular access, with options including arterovenous fistula (AVF), arterovenous graft (AVG), and tunneled cuffed catheters (TCC).
  • The choice of vascular access may influence patient inflammatory status, monocyte function, and cellular senescence.

Purpose of the Study:

  • To investigate the association between different vascular access types (AVF, AVG, TCC) and inflammatory markers, monocyte activation, and senescence in hemodialysis patients.

Main Methods:

  • 126 hemodialysis patients (51 AVF, 32 AVG, 43 TCC) and 40 healthy controls were analyzed.
  • Serum levels of albumin, CRP, IL-6, and TNF-a were measured.
  • Monocyte surface expression of CD14, CD44, CD32, and the percentage of CD14+CD32+ senescent monocytes were assessed.

Main Results:

  • AVG and TCC groups showed higher levels of inflammatory markers (CRP, TNF-a, IL-6) compared to the AVF group.
  • Monocyte activation markers (CD14, CD32, CD44) were upregulated in TCC patients versus AVF patients.
  • No significant differences in inflammatory markers or monocyte activation were found between AVG and TCC groups, nor in the percentage of senescent monocytes across groups.

Conclusions:

  • Arterovenous grafts and tunneled cuffed catheters are associated with heightened inflammatory responses and increased monocyte activation and senescence compared to arterovenous fistulas.
  • These findings highlight the impact of vascular access type on the systemic inflammatory milieu in hemodialysis patients.
Abstract

Related Concept Videos

Hemodialysis I: Introduction01:25

Hemodialysis I: Introduction

Hemodialysis (HD) is a medical treatment that artificially removes waste products, excess fluids, and toxins from the blood when the kidneys are no longer able to perform these functions effectively. In this process, blood is filtered through a semipermeable membrane, allowing for the selective removal of waste while preserving necessary components like blood cells and proteins. Hemodialysis is typically performed in patients with end-stage renal disease (ESRD) or severe kidney...
Hemodialysis II: Procedure and Complications01:24

Hemodialysis II: Procedure and Complications

DialyzersA hemodialysis (HD) dialyzer is a plastic cartridge containing thousands of parallel hollow fibers, which serve as semipermeable membranes. These fibers are typically made from cellulose-based or other synthetic materials. During HD, blood is pumped into the top of the cartridge and distributed among these fibers. Simultaneously, dialysis fluid, known as dialysate, is introduced into the bottom of the cartridge, bathing the outside of the fibers. Across the semipermeable membrane,...
Hemodialysis III: Nursing Management01:25

Hemodialysis III: Nursing Management

The nursing management of a patient undergoing hemodialysis includes several critical steps, starting with a thorough assessment before the procedure.Before the Hemodialysis ProcedureFirst, record the patient's vital signs—blood pressure, heart rate, respiratory rate, and temperature—to establish a baseline. This baseline is essential for detecting conditions such as hypotension that could impact the patient's response to dialysis. Document the patient's pre-dialysis weight, as this measurement...
Inflammation01:38

Inflammation

Overview